Baxter Total Assets 2010-2025 | BAX
Baxter total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
- Baxter total assets for the quarter ending March 31, 2025 were $21.304B, a 23.33% decline year-over-year.
- Baxter total assets for 2024 were $25.782B, a 8.82% decline from 2023.
- Baxter total assets for 2023 were $28.276B, a 0.04% decline from 2022.
- Baxter total assets for 2022 were $28.287B, a 15.61% decline from 2021.
| Baxter Annual Total Assets (Millions of US $) |
|
|---|---|
| 2024 | $25,782 |
| 2023 | $28,276 |
| 2022 | $28,287 |
| 2021 | $33,521 |
| 2020 | $20,019 |
| 2019 | $18,193 |
| 2018 | $15,720 |
| 2017 | $17,111 |
| 2016 | $15,546 |
| 2015 | $20,962 |
| 2014 | $26,138 |
| 2013 | $25,224 |
| 2012 | $20,390 |
| 2011 | $19,073 |
| 2010 | $17,489 |
| 2009 | $17,354 |
| Baxter Quarterly Total Assets (Millions of US $) |
|
|---|---|
| 2025-03-31 | $21,304 |
| 2024-12-31 | $25,782 |
| 2024-09-30 | $26,676 |
| 2024-06-30 | $26,312 |
| 2024-03-31 | $27,788 |
| 2023-12-31 | $28,276 |
| 2023-09-30 | $30,656 |
| 2023-06-30 | $27,885 |
| 2023-03-31 | $28,291 |
| 2022-12-31 | $28,287 |
| 2022-09-30 | $27,965 |
| 2022-06-30 | $31,831 |
| 2022-03-31 | $32,716 |
| 2021-12-31 | $33,521 |
| 2021-09-30 | $19,807 |
| 2021-06-30 | $19,682 |
| 2021-03-31 | $19,466 |
| 2020-12-31 | $20,019 |
| 2020-09-30 | $20,098 |
| 2020-06-30 | $19,465 |
| 2020-03-31 | $19,075 |
| 2019-12-31 | $18,193 |
| 2019-09-30 | $17,299 |
| 2019-06-30 | $17,544 |
| 2019-03-31 | $16,350 |
| 2018-12-31 | $15,720 |
| 2018-09-30 | $16,847 |
| 2018-06-30 | $16,578 |
| 2018-03-31 | $16,890 |
| 2017-12-31 | $17,111 |
| 2017-09-30 | $17,541 |
| 2017-06-30 | $16,963 |
| 2017-03-31 | $15,659 |
| 2016-12-31 | $15,546 |
| 2016-09-30 | $15,795 |
| 2016-06-30 | $15,982 |
| 2016-03-31 | $17,350 |
| 2015-12-31 | $20,962 |
| 2015-09-30 | $20,172 |
| 2015-06-30 | $30,015 |
| 2015-03-31 | $24,861 |
| 2014-12-31 | $26,138 |
| 2014-09-30 | $25,563 |
| 2014-06-30 | $25,629 |
| 2014-03-31 | $25,261 |
| 2013-12-31 | $25,224 |
| 2013-09-30 | $25,250 |
| 2013-06-30 | $23,751 |
| 2013-03-31 | $20,318 |
| 2012-12-31 | $20,390 |
| 2012-09-30 | $19,825 |
| 2012-06-30 | $18,446 |
| 2012-03-31 | $18,784 |
| 2011-12-31 | $19,073 |
| 2011-09-30 | $17,843 |
| 2011-06-30 | $17,741 |
| 2011-03-31 | $17,413 |
| 2010-12-31 | $17,489 |
| 2010-09-30 | $17,563 |
| 2010-06-30 | $16,487 |
| 2010-03-31 | $17,166 |
| 2009-12-31 | $17,354 |
| 2009-09-30 | $16,954 |
| 2009-06-30 | $15,743 |
| 2009-03-31 | $14,953 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $15.539B | $10.636B |
| Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $236.635B | 28.45 |
| Boston Scientific (BSX) | United States | $158.907B | 39.78 |
| Stryker (SYK) | United States | $151.008B | 31.58 |
| EssilorLuxottica (ESLOY) | France | $127.124B | 0.00 |
| Medtronic (MDT) | Ireland | $111.799B | 15.85 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.541B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.605B | 26.59 |
| ResMed (RMD) | United States | $37.830B | 28.41 |
| GE HealthCare Technologies (GEHC) | United States | $33.916B | 16.10 |
| Agilent Technologies (A) | United States | $33.522B | 21.85 |
| Terumo (TRUMY) | Japan | $27.168B | 35.29 |
| Koninklijke Philips (PHG) | Netherlands | $23.091B | 16.20 |
| Insulet (PODD) | United States | $22.110B | 86.79 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.046B | 11.59 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.415B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.567B | 22.85 |
| Lantheus Holdings (LNTH) | United States | $5.664B | 14.29 |
| Prestige Consumer Healthcare (PBH) | United States | $3.946B | 17.63 |
| Perrigo (PRGO) | Ireland | $3.673B | 9.31 |
| Haemonetics (HAE) | United States | $3.584B | 16.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.312B | 27.52 |
| ICU Medical (ICUI) | United States | $3.252B | 23.98 |
| QuidelOrtho (QDEL) | United States | $1.949B | 13.40 |
| LeMaitre Vascular (LMAT) | United States | $1.876B | 41.94 |
| AtriCure (ATRC) | United States | $1.622B | 0.00 |
| Acuren (TIC) | United States | $1.341B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.273B | 12.92 |
| Green Thumb Industries (GTBIF) | United States | $1.167B | 26.24 |
| Neogen (NEOG) | United States | $1.037B | 13.28 |
| Phibro Animal Health (PAHC) | United States | $1.035B | 13.23 |
| BioLife Solutions (BLFS) | United States | $1.023B | 0.00 |
| InMode (INMD) | Israel | $0.913B | 9.20 |
| Kestra Medical Technologies (KMTS) | United States | $0.851B | 0.00 |
| Owens & Minor (OMI) | United States | $0.703B | 5.83 |
| CeriBell (CBLL) | United States | $0.677B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.614B | 0.00 |
| Evolus (EOLS) | United States | $0.594B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.559B | 0.00 |
| Valneva SE (VALN) | France | $0.482B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.454B | 0.00 |
| Surmodics (SRDX) | United States | $0.425B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.417B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.357B | 13.14 |
| Quanterix (QTRX) | United States | $0.332B | 0.00 |
| SNDL (SNDL) | Canada | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 23.03 |
| Cerus (CERS) | United States | $0.270B | 0.00 |
| ZimVie (ZIMV) | United States | $0.260B | 11.84 |
| Sanara MedTech (SMTI) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.252B | 0.00 |
| Brainsway (BWAY) | Israel | $0.248B | 65.75 |
| Aurora Cannabis (ACB) | Canada | $0.238B | 70.67 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| TriSalus Life Sciences (TLSI) | United States | $0.206B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.06 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Omeros (OMER) | United States | $0.176B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.143B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.122B | 15.05 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 11.97 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.080B | 0.00 |
| Zynex (ZYXI) | United States | $0.078B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| MacroGenics (MGNX) | United States | $0.076B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.063B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 58.43 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.70 |
| Rockwell Medical (RMTI) | United States | $0.029B | 0.00 |
| Safety Shot (SHOT) | United States | $0.025B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |